TY - CHAP M1 - Book, Section TI - Evaluation of Patients with Suspected Coronary Artery Disease Using Nuclear Myocardial Perfusion Imaging A1 - Nair, Sanjeev U. A1 - Heller, Gary V. A2 - Heller, Gary V. A2 - Hendel, Robert C. PY - 2017 T2 - Nuclear Cardiology: Practical Applications, 3e AB - The worldwide burden of coronary artery disease (CAD) remains substantial. Annually, an estimated 1.5% of the US population visits the primary care services with symptoms of chest pain.1 Each year over 660,000 patients in the United States present to hospital with either a first myocardial infarction (MI) or sudden cardiac death (SCD) due to CAD.2 Of these 305,000 will have had a recurrent MI. An estimated 160,000 will also suffer a silent first MI.2 CAD is the leading cause of death across the world and is predicted to remain so for the next 20 years. Annually, approximately 3.8 million men and 3.4 million women die from CAD. The number is estimated to rise to 11.1 million deaths globally by 2020.3 An estimated $108.9 billion is spent annually on treatment of CAD and is expected to exceed $320 billion by the year 2030.2 Thus, means and methods to reduce the prevalence, morbidity, and mortality associated with CAD remain of great importance to health care providers. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/04 UR - accesscardiology.mhmedical.com/content.aspx?aid=1145444030 ER -